SpringRock Ventures focuses on investing in the convergence of healthcare and information technology, targeting early to late-stage, high-growth potential companies in areas such as digital health, medical devices, SaaS, and oral health. Their strategy involves partnering with entrepreneurial teams to provide strategic guidance and support for disruptive solutions improving general health.
62% of their portfolio is in Healthcare. Average disclosed round size is $32.7M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Proclaim | Series B | $15M | Jul 2023 |
 DexCare | Series C | $75M | Jun 2023 |
 Carrum Health | Series B | $45M | May 2023 |
 Vouched | Series A | $6.3M | Feb 2023 |
| DexCare | Series B | $50M | Jan 2022 |
| DexCare | Series A | $20M | Mar 2021 |
| Carrum Health | Series A | $40M | Jan 2021 |
 GRIN | Seed | $10M | — |
Top Co-Investors
Frist Cressey Ventures3 shared
Kaiser Permanente Ventures3 shared
Providence Ventures2 shared
Transformation Capital2 shared
Tiger Global Management2 shared
Cross Creek2 shared
Wildcat Capital Management2 shared
TriVentures1 shared
Mass General Brigham Ventures1 shared
Iconiq Capital1 shared
Khosla Ventures1 shared
OMERS Ventures1 shared
Revelation Partners1 shared
Last updated: 16 April 2026